Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes-Reference-Cited by-同舟云学术

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes

Published:2010-11-09 Issue:12 Volume:27 Page:1409-1419
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Forst T.,Uhlig-Laske B.,Ring A.,Graefe-Mody U.,Friedrich C.,Herbach K.,Woerle H.-J.,Dugi K. A.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2010.03131.x/fullpdf

Reference31 articles.

1. Metformin;Bailey;N Engl J Med,1996

2. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2006

3. Oral antihyperglycemic therapy for type 2 diabetes: scientific review;Inzucchi;J Am Med Assoc,2002

4. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group;De Fronzo;N Engl J Med,1995

5. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus;Campbell;Ann Pharmacother,2007

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. Diabetes mellitus bei Patient:innen mit Leberzirrhose – eine besondere therapeutische Herausforderung;Journal für Gastroenterologische und Hepatologische Erkrankungen;2024-05-15

3. An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus;International Journal of Molecular Sciences;2023-05-26

4. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature;Frontiers in Molecular Biosciences;2023-05-23

5. Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use;Pharmacy & Pharmacology;2023-04-28